Select Medical Holdings Corporation Q2 Earnings Call: A Fundamental and Technical Analysis

🌥️Introduction:

Select Medical Holdings Corporation is scheduled to report its Q2 earnings results on August 4th, 2023, at 9:00 AM EST. As investors eagerly await the release of the earnings report, it is essential to assess the company’s performance from a fundamental and technical standpoint, review historical guidance, and consider analysts’ estimates. This article aims to provide an engaging analysis of Select Medical’s upcoming earnings call, highlighting key factors that investors should consider.

Fundamental Analysis:

	ReportDate	NetIncome	TotalRevenue	DilutedEPS	unit
Q2	2023-06-30	78.2	1674.5	0.61	million USD
Q1	2023-03-31	70.8	1665.0	0.56	million USD
Q4	2022-12-31	27.5	1581.5	0.22	million USD
Q3	2022-09-30	27.2	1567.8	0.21	million USD
Q2	2022-06-30	55.2	1584.7	0.43	million USD

Looking at Select Medical Holdings Corporation‘s past year financials, there has been a steady increase in both net income and total revenue. In the second quarter of 2023, the company recorded a net income of $78.2 million and total revenue of $1674.5 million. The growth in net income and total revenue indicates a positive trajectory for the company.

Furthermore, Select Medical’s diluted EPS for the second quarter was $0.61 million, reflecting an increase compared to the previous quarters. The consistent growth in EPS demonstrates the company’s ability to generate profits and enhance shareholder value.

Technical Analysis:

	since	low	high	change	change%
1D	2023-08-07	29.7	30.3	0.3	0.9
5D	2023-08-01	29.4	32.0	0.3	1.0
1M	2023-07-07	29.4	33.5	0.6	2.0
3M	2023-05-08	26.7	33.5	0.4	1.4

Examining Select Medical’s price performance over the past three months, we can observe a consistent upward trend. The stock has experienced a steady increase, with a 1-day change of 0.9% and a 3-month change of 1.4%. These positive price movements suggest that market sentiment towards Select Medical is optimistic, hinting at potential positive results in the upcoming earnings call.

Historical Guidance:

Taking into account Select Medical’s past earnings reports, there is reason to anticipate positive news during the upcoming earnings call. The company has shown consistent growth in net income and total revenue in recent quarters, reflecting strong operational performance.

Analysts Estimates:

According to MorningStar consensus estimates, analysts anticipate Select Medical Holdings Corporation to report Adjusted EPS of $0.56 for the current quarter. It is noteworthy that the consensus estimate has remained unchanged over the past seven days. This stability in analysts’ expectations further reinforces the positive sentiment surrounding the company’s future prospects.

Conclusion:

Based on a thorough analysis of Select Medical Holdings Corporation‘s fundamental and technical aspects, historical guidance, and analysts’ estimates, the upcoming Q2 earnings call appears promising. The company has consistently delivered strong financial performance, with increasing net income and total revenue. The positive price performance of Select Medical’s stock further indicates confidence in the company’s future prospects.

Investors and stakeholders are encouraged to tune in to the earnings call, as it will provide important insights into Select Medical’s overall performance, strategic initiatives, and growth prospects. The transparency and information shared during the call will enable investors to make well-informed decisions based on concrete data.

By assessing the data provided in this article, investors can gain a comprehensive understanding of Select Medical Holdings Corporation‘s current standing and potential for future growth. Keep an eye on this healthcare provider as it continues its journey towards success.

Disclaimer: The information provided in this article is based solely on the given data and should not be considered as financial advice. Investors are encouraged to conduct their own research and seek professional advice before making any investment decisions.